US life sciences company Thermo Fisher Scientific said that it will collaborate with China-based WuXi Diagnostics and Mayo Clinic to develop a total antibodies Covid-19 test called the Thermo Scientific OmniPath COVID-19 Total Antibody ELISA test. The new antibody test development is said to emerge from an ongoing partnership between the three organizations, which includes […]
Continue reading …
Sorrento Therapeutics said that STI-1499, its anti-SARS-CoV-2 antibody, showed 100% inhibition of SARS-CoV-2 virus infection in an in vitro virus infection experiment at a very low antibody concentration. The US biotech company will look to create an antibody cocktail product that will work as a protective shield against SARS-CoV-2 coronavirus infection and stay effective even […]
Continue reading …
Abbott has been granted emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its SARS-CoV-2 IgG lab-based serology blood test, a COVID-19 antibody blood test, on the Alinity i system. The US medical device company will look to ship close to 30 million antibody tests across the world this world across […]
Continue reading …
US nutraceutical company Bonne Santé Group has launched Bonne Santé Natural Immunology, a new range of nutraceutical products designed to boost the immune system functions. Bonne Santé Natural Immunology is made up of three separate products that use proprietary formulas created by Jorge Lamazares, the chief formulator of the company. Included in the Bonne Santé […]
Continue reading …
Remdesivir EUA status : The US has officially pushed the use of remdesivir for treating the novel coronavirus with the Food and Drug Administration (FDA) granting emergency use authorization (EUA) to the investigational COVID-19 drug candidate being developed by Gilead Sciences. The EUA lets the antiviral drug candidate to be used for the treatment of […]
Continue reading …
Eiger BioPharmaceuticals said that it has dosed the first patients in a phase 2 trial of its hepatitis delta virus drug candidate peginterferon lambda (Lambda) in outpatients at the Stanford University School of Medicine having mild COVID-19. The California-based biopharma company said that nearly 120 patients will be randomly grouped in a 1:1 ratio to […]
Continue reading …CytoAgents, Quotient Sciences to take COVID-19 drug candidate GP1681 into human trials
April 29, 2020 No Comment
US biotech company CytoAgents has joined forces with CDMO and CRO services provider Quotient Sciences to accelerate the development of its COVID-19 drug candidate GP1681 into human clinical trials for the treatment of cytokine storm. According to the partners, scientific consensus is building that severe illness resulting from COVID-19 and other infectious diseases is triggered by […]
Continue reading …
Citius Pharmaceuticals has made a Pre-IND submission to the US Food and Drug Administration for a novel stem cell therapy for acute respiratory distress syndrome (ARDS) in COVID-19 patients. In this regard, the late-stage specialty pharma company submitted a pre-IND meeting request and supporting briefing documents to the FDA’s Center for Biologics Evaluation and Research […]
Continue reading …
Shanghai Fosun Pharmaceutical (Fosun Pharma) has been granted the emergency use authorization (EUA) status for its COVID-19 RT-PCR detection kit from the US Food and Drug Administration (FDA). Fosun Long March, a fully-owned subsidiary of Fosun Pharma, developed the COVID-19 RT-PCR detection kit which already has a medical device registration certificate from the China National Medical […]
Continue reading …SARS-CoV-2 vaccine trial : Sinovac Biotec begins COVID-19 vaccine candidate human trial
April 25, 2020 No Comment
SARS-CoV-2 vaccine trial : Chinese biopharma company Sinovac Biotech has started a phase 1 clinical trial for SARS-CoV-2 vaccine, its COVID-19 vaccine candidate in 144 healthy adults, aged between 18 and 59. Sinovac Biotech had recently secured approval from China’s National Medical Products Administration (NMPA) to launch the randomized, double-blinded, placebo-controlled study for the coronavirus […]
Continue reading …
Business News Today
- Analog Devices to acquire Maxim Integrated Products for $21bn
- Muscle Shoals solar project : Ørsted acquires 294MW solar plant from Longroad Energy
- Pekan solar power plant : Jacobs wins contract from Hanwha Energy
- Allianz completes €500m acquisition of SulAmérica’s auto and other P&C operations
- E.ON sells innogy Ceska republika to Hungarian power company MVM Group
- KKR to acquire US life insurance company Global Atlantic Financial for $4.4bn
- Rewa Ultra Mega Solar Power project in Madhya Pradesh, India commissioned
- Nestlé Nespresso to expand Romont production center with $170m investment
- San Francisco-based fintech Taulia raises $60m in new funding round
- Mars unveils new chocolate bar – SNICKERS Peanut Brownie
